Schedule 13D ownership disclosure

Translate Bio, Inc.

Security class unavailable

Event date: 2018-10-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,697,912
Percent of class
8.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000903423-18-000559
Form type
SC 13D/A
Filer
GSK plc
CIK
CIK 1131399
Filed
Oct 17, 2018
Reporting period
Oct 12, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub